/
/
/

Medicamen Biotech Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)282.00
Volume (₹)60,359.00
High (₹)287.80
Upper Circuit335.10
Low (₹)275.00
Lower Circuit223.40
Prev Close279.25
52W High (₹)447.65
Price286.00
52W Low (₹)212.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)376.03 Cr
Div. Yield (%)0.36
PE Ratio34.72
Debt to Equity0.16
Price to Book2.97
Book Value162.23
EPS (TTM)7.98
Face Value10.00
ROE (%)3.23

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MEDICAMEQNSE
LTP
1W Low
1W High
Market cap (₹)
1885.9-30.1 (-1.57%)
1876.80
1917.30
4,55,826Cr
9575+325 (3.51%)
9100
9588
2,47,019Cr
4960+54.5 (1.11%)
4823
4983.50
1,86,875Cr
1145.5+2.5 (0.22%)
1114.10
1167.70
1,15,212Cr
1384-10.7 (-0.77%)
1375.50
1399.10
1,12,773Cr
1946.9+78.4 (4.20%)
1832.70
1952
1,00,944Cr
2104.7-27.3 (-1.28%)
2094.60
2148
96,255Cr
2309-59.8 (-2.52%)
2301
2390
95,911Cr
1151-4 (-0.35%)
1141.80
1166.80
95,571Cr
1692+54.7 (3.34%)
1622.60
1698.80
95,398Cr
286+26.6 (10.25%)
260.65
288
376Cr

Key Highlights of Medicamen Biotech Ltd Balance Sheet

Medicamen Biotech Ltd balance sheet discloses shareholders' funds of ₹12.71Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹12.71Cr, and the reserves and surplus of the company is ₹204.92Cr.

The company has its non-current liabilities with total liabilities of ₹290.38Cr as of 2025-03-31.

The current liabilities are ₹72.58Cr as of 2025-03-31. At the same time, current assets are ₹153.51Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹8.06Cr and tangible assets of ₹86.31Cr, provided in the Medicamen Biotech Ltd financial statements.